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Introduction
The symptoms of human infections with dengue virus are often 
so similar to those of infection with chikungunya virus that 
clinical differentiation of the two types of infection is difficult. 
Infection with chikungunya virus, which belongs to the genus 
Alphavirus in the family Togaviridae, can cause conjunctivitis, 
debilitating polyarthralgia, diarrhoea, headache, fatigue, fever, 
myalgia, nausea, rashes and vomiting.1 Infection with dengue 
virus, which belong to the genus Flavivirus in the family Fla-
viviridae, is also often associated with severe joint pain and 
can lead to dengue fever or to the potentially deadly severe 
dengue. Aedes aegypti and Ae. albopictus are the main vectors 
of both chikungunya and dengue virus.
Although the disease we now call chikungunya appears 
to have been initially described in the 1820s, almost simul-
taneously in East Africa – the area now known as the United 
Republic of Tanzania – and India, chikungunya virus was not 
isolated until 1952.1–3 Human infections with this virus were 
reported in Bangkok, Thailand, in the 1960s and in India be-
tween 1963 and 1973.4–6 Such infections may rapidly develop 
into large epidemics. In 2006 on an overseas department of 
France – the island of La Réunion – there was an epidemic 
where the incidence of chikungunya peaked at more than 
40 000 cases per week.7 By early 2013, chikungunya had been 
reported in Africa, Asia, Europe and parts of Oceania.8
Since both Ae. aegypti and Ae. albopictus occur in Haiti, 
chikungunya virus was expected to arrive in the country and 
to be disseminated rapidly.9,10 In December 2013, the World 
Health Organization (WHO) reported the local spread of 
the virus in nearby Saint Martin – another overseas depart-
ment of France.11 On 6 June 2014, the United States Centers 
for Disease Control and Prevention (CDC) reported 6318 
chikungunya cases in Haiti and, by the end of 2014, transmis-
sion of chikungunya virus had been reported throughout the 
Caribbean basin.12,13
Because the symptoms and epidemiology of chikungunya 
and dengue fever are similar and occur against a backdrop of 
other infectious diseases, our objective was to identify and 
assess immunoglobulin G (IgG) responses to these closely 
related pathogens. A search, on 6 November 2015, for both 
“multiplex” and “chikungunya” in the titles and abstracts 
of the published articles listed by PubMed resulted in a list 
of 21 articles. Of these articles, nine described laboratory 
techniques based on the reverse-transcription polymerase 
chain reaction, two used assays based on the same reaction to 
identify chikungunya virus in the field14,15 and one described 
an antibody-neutralization technique.16 As multiplex bead 
assays allows the simultaneous collection of data on antibody 
responses to multiple antigens,17–23 we investigated the use of 
such an assay to assess the IgG responses to antigens from 
chikungunya and dengue virus and Plasmodium falciparum 
in Haitian children. Our post-hoc testing of blood samples 
was primarily done to generate epidemiological data about 
the introduction of chikungunya virus in Haiti and was not 
aimed at diagnosis or case management.
Objective To differentiate exposure to the newly introduced chikungunya virus from exposure to endemic dengue virus and other 
pathogens in Haiti.
Methods We used a multiplex bead assay to detect immunoglobulin G (IgG) responses to a recombinant chikungunya virus antigen, two 
dengue virus-like particles and three recombinant Plasmodium falciparum antigens. Most (217) of the blood samples investigated were 
collected longitudinally, from each of 61 children, between 2011 and 2014 but another 127 were collected from a cross-sectional sample 
of children in 2014.
Findings Of the samples from the longitudinal cohort, none of the 153 collected between 2011 and 2013 but 78.7% (48/61) of those 
collected in 2014 were positive for IgG responses to the chikungunya virus antigen. In the cross-sectional sample, such responses were 
detected in 96 (75.6%) of the children and occurred at similar prevalence across all age groups. In the same sample, responses to malarial 
antigen were only detected in eight children (6.3%) but the prevalence of IgG responses to dengue virus antigens was 60.6% (77/127) 
overall and increased steadily with age. Spatial analysis indicated that the prevalence of IgG responses to the chikungunya virus and one of 
the dengue virus-like particles decreased as the sampling site moved away from the city of Léogâne and towards the ocean.
Conclusion Serological evidence indicates that there had been a rapid and intense dissemination of chikungunya virus in Haiti. The multiplex 
bead assay appears to be an appropriate serological platform to monitor the seroprevalence of multiple pathogens simultaneously.
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Methods
Study population and design
The study protocol was reviewed and 
approved by the Ethics Committee of 
the Hôpital Sainte Croix, Léogâne, Haiti, 
and the Institutional Review Boards of 
both the CDC, Atlanta, United States of 
America, and the University of Notre 
Dame, Notre Dame, USA.
We collected blood spot samples 
from a longitudinal cohort of 61 chil-
dren – all residents in the small coastal 
town of Ca Ira – at three or all four of 
four time points: December 2011, Feb-
ruary 2013, December 2013 and August 
2014. All the blood spot samples col-
lected before 2014 had been collected, 
from children who were aged 2–10 years 
in December 2011, for filariasis surveil-
lance. In August 2014, specifically for 
our investigation of the bead assay, we 
collected blood from all 61 previously 
sampled children and from another 127 
children from Ca Ira, then aged 2–10 
years, who had not been sampled before. 
We considered the 127 children to rep-
resent a cross-sectional sample.
Prior to the collection of each blood 
spot sample, a local community health 
worker obtained the informed consent 
from a parent of the sampled child. To 
prepare each sample, 10 µl whole blood 
was collected from a finger-prick and 
transferred to one unused extension of 
a piece of filter paper with six circular 
extensions (TropBio Pty Ltd, Townsville, 
Australia). After collection, the blood 
spots were allowed to dry and then 
stored at −20 °C until tested.18
Antigens
We used one recombinant chikungunya 
virus antigen – that is, mutant A226V 
envelope 1 antigen (CTK Biotech, 
San Diego, USA) – two dengue virus 
antigens – propagated using a eukary-
otic plasmid vector that expressed the 
premembrane/membrane and enve-
lope proteins that self-assemble into 
two different non-infectious virus-like 
particles known as DENV-2 and DENV-
324,25 – and three recombinant antigens 
based on merozoite surface protein 1 of 
P. falciparum.26–29 The DENV-2 virus-
like particle has epitopes for antibod-
ies to dengue virus serotypes 2 and 4 
whereas the DENV-3 has epitopes for 
antibodies to serotypes 3 and 1.30 The 
recombinant P. falciparum antigens 
represented a 42-kDa fragment from 
clone FVO, a 42-kDa fragment from 
clone 3D7 and a 19-kDa fragment from 
clone 3D7 (Zentrum für Molekulare 
Biologie der Universität Heidelberg, 




carbodiimide (Calbiochem, Woburn, 
USA) was used to convert the carboxyl 
groups on carboxylated polystyrene 
beads (SeroMap Beads; Luminex Cor-
poration, Austin, USA) to esters. The 
esters on the so-called activated beads 
could then react with amine groups on 
the antigens to form covalent amide 
bonds between the beads and the anti-
gens. We coupled 12.5 million activated 
beads – in phosphate-buffered saline 
at pH 7.2 – with 30 µg of each dengue 
virus-like particle and 7.5 µg of the chi-
kungunya virus antigen. For the malaria 
antigens and glutathione-S-transferase, 
we coupled 12.5 million activated beads, 
in 50 mmol/L 2-(N-morpholino) eth-
anesulfonic acid buffer with 0.85% (w/v) 
NaCl, at pH 5.0 – with 28 µg of the 19-
kDa fragment, from clone 3D7, linked 
to glutathione-S-transferase, 15 µg of the 
42-kDa fragment from clone 3D7, 15 µg 
of the 42-kDa fragment from clone FVO, 
and 12 µg of glutathione-S-transferase. 
Coupling efficiency was evaluated using 
monoclonal antibodies and reference 
sera that were known to be highly reac-
tive to the antigens.31,32
Blood spot elution
Each dried blood spot was eluted 
overnight, at 6 °C, in 500 µL of a buffer 
consisting of phosphate-buffered saline, 
at pH 7.2, containing 0.5% (w/v) bovine 
serum albumin, 0.5% (w/v) polyvinyl al-
Table 1. Reference values and positivity thresholds for a multiplex bead assay based on 
antigens from chikungunya and dengue viruses and Plasmodium falciparum
Pathogen, antigen Reference 
samplea
Fluorescence intensityb




Envelope 1 antigen of mutant A226V Blood 101 (−9 to 30 027) 640
Dengue virus
DENV-2 virus-like particle Sera 10 168 (−18 to 28 395) 982
DENV-3 virus-like particle Sera 15 047 (3 to 30 214) 3615
Plasmodium falciparum
19-kDa fragment of MSP-1 of clone 3D7, 
linked to GST
Sera 8 (−6 to 21 627) 105
42-kDa fragment of MSP-1 of clone 3D7 Sera 29 (2 to 23 913) 189
42-kDa fragment of MSP-1 of clone FVO Sera 20 (0 to 20 489) 79
GSTc Sera 7 (−4 to 173) NA
GST: glutathione-S-transferase; MSP-1: merozoite surface protein 1; NA: not applicable.
a  The reference samples were 86 sera from adults who claimed to have never left the United States or 156 
spots of blood collected from 62 Haitian children between 2011 and 2013.
b  Each reported intensity is the result of subtracting background fluorescence, from wells containing no 
primary antibody, from the mean of the median fluorescence intensities of duplicate wells.
c  Used as a protein-negative control.
Table 2. Percentages of blood spots from 61 Haitian children found bead-assay-positive 
for immunoglobulin G responses to antigens representing chikungunya and 
dengue viruses and Plasmodium falciparum, 2011–2014









Chikungunya virus 0 (0) 0 (0) 0 (0) 48 (78.7)
Dengue virus 38 (62.3) 27 (79.4) 49 (80.3) 48 (78.7)
Plasmodium 
falciparum
7 (11.5) 1 (2.9) 5 (8.2) 4 (6.6)
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cohol, 0.8% (w/v) polyvinylpyrrolidone, 
0.5% (w/v) casein, 0.3% (w/v) Tween 
20 and 0.02% (w/v) sodium azide. To 
adsorb any antibodies to Escherichia 
coli – that might have reacted with E. 
coli proteins inadvertently coupled to the 
beads – each elution was diluted 1:4 with 
the same buffer containing sufficient 
crude E. coli extract to give a final con-
centration of 3.0 µg extract per mL.17 All 
serum specimens were diluted, 1:400, in 
the same buffer with the E. coli extract.
Bead assay
Procedure
The E. coli-treated samples were stored 
overnight at 6 °C and then clarified by 
centrifugation at 20 238 g for 10 minutes. 
All incubation steps were conducted at 
room temperature – i.e. 20–22 °C – in 
96-well filter-bottom plates (Merck 
KGaA, Darmstadt, Germany). For each 
assay, a 50-µl clarified sample was added 
to a single well containing 1500 antigen-
coupled beads from each coupled-bead 
classification and incubated, with gentle 
shaking, for 1.5 hours. The assay was 
then run as previously described.17 Me-
dian fluorescence intensities between 
1 and 32 766 were evaluated in a plate 
reader (Luminex Corporation, Austin, 
USA) equipped with Bio-Plex Manager 
6.1 software (Bio-Rad, Hercules, USA). 
The background fluorescence – from 
wells containing no primary antibody 
– was subtracted from the mean of 
the median fluorescence intensities of 
duplicate wells to yield background-
adjusted median fluorescence intensi-
ties. To evaluate inter-plate consistency, 
positive controls, diluted to yield low to 
moderate fluorescence intensities, were 
run on each plate.
Positivity thresholds
For setting the threshold for assay 
positivity for the chikungunya virus 
antigen, we used assay results for the 
blood spots collected, before 2014, 
from the longitudinal cohort of Haitian 
children. For all the other thresholds, we 
used the bead assay to test 86 sera from 
adults who claimed to have never left 
the United States (Table 1). Any serum 
with background-adjusted fluorescence 
more than 3.0 standard deviations above 
the mean was considered to be an out-
lier and ignored. For each antigen, the 
threshold for assay positivity was set as 
the mean background-adjusted result 
plus 3.0 standard deviations for the 
relevant non-outliers.
A test blood spot was considered 
positive for an IgG response to P. falci-
parum if it was found positive for at least 
two of the three P. falciparum antigens 
we investigated. A test blood spot was 
considered positive for an IgG response 
to dengue virus if it was found positive 
for one or both of the virus-like particles 
we investigated.
Validating assay for chikungunya antigen
We used both the bead assay and an 
enzyme-linked immunosorbent assay 
(ELISA) to test 78 sera – i.e. 26 sera 
collected from Haitian adults in 1996, 
when chikungunya was known to be 
present in Cambodia but not in Haiti,13 
and 52 sera collected from Cambodian 
adults in 2012 – for IgG that reacted with 
chikungunya virus antigen. The viral 
antigen used in the ELISA came from 
the brain of a suckling mouse and was 
captured with a monoclonal antibody.33 
Any IgG from a test serum that reacted 
with this antigen was probed with goat 
anti-human IgG linked to alkaline phos-
phatase. Colour was developed using 
disodium p-nitrophenyl phosphate and 
read at 405 nm.33
Spatial analysis
The positions of the 143 households that 
participated in the blood spot collection 
in August 2014 were mapped using a 
global positional system and ArcGIS 
software (ESRI, Redlands, USA). The 
same software was then used to perform 
a so-called hot-spot analysis of the cor-
responding bead assay results for three 
of the test antigens: chikungunya virus, 
the DENV-2 virus-like-particle and the 
19-kDa malarial antigen linked to glu-
tathione-S-transferase. For this analysis, 
we used a 400-m zone of indifference to 
reflect the mean range of an adult female 
Ae. aegypti.34 To prevent association of 
the results with household locations, 
we aggregated the Z-scores for the Ge-
tis–Ord Gi statistic35 and displaced the 
corresponding symbols from the actual 
locations.
Fig. 1. Fluorescence intensities recorded in multiplex bead assays based on antigens 
























CHIKV E1 DENV-2 DVLP DEN-3 DVLP MSP-1 antigens
Dec 2011 Feb 2013 Dec 2013 Aug 2014
CHIKV E1: chikungunya virus envelope 1; DVLP: dengue virus-like particle; MSP-1: merozoite surface protein 1.
Notes: The assays were used to investigate blood spots from a longitudinal cohort of 61 children. The 
intensities shown are each the result of subtracting background fluorescence, from wells containing no 
primary antibody, from the mean of the median fluorescence intensities of duplicate wells. The three P. 
falciparum antigens tested – i.e. 19-kDa, 42-kDa and 42-kDa fractions of the MSP-1 clones 3D7, 3D7 and 
FVO, respectively, gave almost identical results.
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Statistics
We used Spearman’s correlation to inves-
tigate the levels of association between 
the IgG responses for the test antigens. 
A P-value of less than 0.05 was consid-
ered indicative of statistical significance. 
Inter-plate consistency was evaluated as 
the percentage coefficient of variation 
for the diluted positive controls.
Results
The positivity thresholds are summa-
rized in Table 1. Inter-plate consistency 
was good, with the percentage coefficient 
of variation always less than 10.6. In the 
bead assay, monoclonal antibodies and 
sera known to be highly reactive to the 
antigens gave high background-adjusted 
fluorescence intensities, indicating 
antigen integrity and adequate antigen 
coupling.31,32,36
Validation
In the capture ELISA, using chikun-
gunya virus from a mouse, only 50 of 
the 78 tested sera gave interpretable 
results.33 When the results of this assay 
were considered to be the so-called gold 
standard, the bead assay appeared to be 
90% sensitive and 85% specific.
Longitudinal cohort
Prevalence of pathogen exposure
Within the longitudinal cohort (Ta-
ble 2), no evidence of exposure to chi-
kungunya virus was observed from 2011 
to 2013 but 78.7% (46/61) of the samples 
tested in 2014 showed evidence of such 
exposure. The prevalence of exposure to 
dengue virus rose from 62.3% (38/61) 
in December 2011 to 79.0% (27/34) in 
February 2013 and then remained rela-
tively unchanged for the remainder of 
the study. The corresponding prevalence 
of P. falciparum never exceeded 12% 
throughout the study. No exposure to 
any of the three pathogens investigated 
was evident in 4.9% (3/61) of the longi-
tudinal cohort.
Temporal trends
The temporal trends in the background-
adjusted fluorescence intensities are 
summarized in Fig. 1. In the assays 
based on chikungunya virus antigen, 
the median intensities were low between 
2011 and 2013 but rose sharply in 2014. 
In contrast, in the assays based on either 
of the dengue antigens we tested, median 
intensities were relatively low in 2011 
and increased through 2013 but then 
fell slightly in 2014. In the assays based 
on any of the malarial antigens, median 
intensities remained low throughout the 
study period.
Results for one child
The assay results for one child who was 
sampled at each of the four time points 
are summarized in Fig. 2. This child was 
only found to have high IgG responses to 
the chikungunya virus antigen in 2014. 
In the bead assays based on the dengue 
virus-like-particles, this child was found 
barely to exceed the positivity threshold 
in December 2011, to be negative in 
February 2013 and then to be well over 
the positivity threshold in December 
2013 – demonstrating a secondary im-
mune response to the dengue antigens. 
The child was never found positive in 
the assays for malarial antigens.
Cross-sectional sample
Prevalence of pathogen exposure
Of the 127 children who each provided 
a single blood spot in 2014, 96 (75.6%), 
77 (60.6%) and eight (6.3%) were found 
seropositive for chikungunya virus, den-
gue virus and P. falciparum, respectively, 
and 17 (13.4%) showed no evidence of 
exposure to any of these pathogens.
Age-specific trends
In the assays based on dengue virus 
antigens, median intensities (Fig. 3) and 
prevalence (Fig. 4) increased with the 
age of the child. In the assays based on 
chikungunya virus antigen or malarial 
antigens, however, there was no indica-
tion that age had any effect on median 
intensities (Fig. 3) or prevalence (Fig. 4).
Correlations
Inter-pathogen
The Spearman’s correlations indicated 
no significant cross-reactivity among 
our three study pathogens – i.e. between 
chikungunya virus and either dengue 
virus (r2 < 0.08; P > 0.12) or P. falciparum 
(r2 < −0.1; P > 0.5) or between dengue vi-
rus and P. falciparum (r2 < 0.09; P > 0.08).
Inter-antigen
In contrast, in terms of positivity in the 
bead assays, a strong correlation existed 
among the three malaria antigens (r2 
Fig. 2. Fluorescence intensities, for one child, recorded in multiplex bead assays based 
























CHIKV E1 DENV-2 DVLP DEN-3 DVLP MSP-1 antigens
Dec 2011 Feb 2013 Dec 2013 Aug 2014
CHIKV E1: chikungunya virus envelope 1; DVLP: dengue virus-like particle; MSP-1: merozoite surface protein 1.
Notes: The intensities shown are each the result of subtracting background fluorescence, from wells 
containing no primary antibody, from the mean of the median fluorescence intensities of duplicate wells. 
The three P. falciparum antigens tested – i.e. 19-kDa, 42-kDa and 42-kDa fractions of the MSP-1clones 3D7, 
3D7 and FVO, respectively, gave almost identical results. In December 2011, the child was aged two years.
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> 0.59; P < 0.001) and between the two 
dengue antigens (r2 = 0.96; P < 0.001).
Spatial analysis
Clusters identified in the spatial analysis 
of the study area, which lies immediately 
outside urban Léogâne, are shown in 
Fig. 5 (available at: http://www.who.
int/bulletin/volumes/94/11/16-173252). 
In general, the detected IgG responses 
to the chikungunya virus antigen and 
DENV-2 virus-like particle appeared to 
get weaker the further north-west the 
sampling site – i.e. the further away from 
the city of Léogâne and the closer to the 
ocean. Conversely, the corresponding 
responses to the 19-kDa malarial anti-
gen linked to glutathione-S-transferase 
exhibited no discernible spatial pat-
tern – although they were, in general, 
relatively weak.
Discussion
The results from the bead assay indicate 
that infection with chikungunya virus 
only became common in Haiti in 2014 
and that there was rapid transmission of 
the virus after its introduction into an 
immunologically naive Haitian popula-
tion. By the first week of 2015, there were 
64 695 suspected cases of chikungunya 
virus infection in Haiti and – since there 
were over 500 000 cases reported, at the 
same time, in the neighbouring Domini-
can Republic – even this high number 
is likely to have been an underestimate 
because of underreporting.13 A nation-
wide household survey conducted by 
the Igarapé Institute indicated that 9.2% 
of Haitians had been infected with the 
virus by May 2014 – meaning there had 
been almost one million cases of infec-
tion within a month of the introduction 
of the virus into Haiti.37 Such an explo-
sive outbreak was also indicated by our 
bead assay results, which indicated that 
the prevalence of exposure to chikungu-
nya virus among children in the town of 
Ca Ira increased from 0% (0/61) in 2013 
to 76.6% – i.e. 144 of the 188 children in 
the combined longitudinal cohort and 
cross-sectional sample – in 2014.
Our bead assay was sensitive 
enough to show both an initial im-
mune response and an anamnestic 
response to the DENV-2 and DENV-3 
virus-like-particles and it appeared to be 
unaffected by cross-reactivity among the 
three pathogens we investigated. It also 
indicated an increasing gradient, in the 
Fig. 3. Age-specific fluorescence intensities recorded in multiplex bead assays based 
























CHIKV E1 DENV-2 DVLP DEN-3 DVLP MSP-1 antigens
2 to < 4 4 to < 6 6 to < 8 8 to < 10 10 to 14
CHIKV E1: chikungunya virus envelope 1; DVLP: dengue virus-like particle; MSP-1: merozoite surface protein 1.
Notes: The assays were used, with six test antigens, to investigate blood spots from a cross-sectional sample of 
127 children. The fluorescence intensities shown are each the result of subtracting background fluorescence, 
from wells containing no primary antibody, from the mean of the median fluorescence intensities of duplicate 
wells. As the three P. falciparum antigens tested – i.e. 19-kDa, 42-kDa and 42-kDa fractions of the MSP-1 clones 
3D7, 3D7 and FVO, respectively – gave almost identical results, they are not shown separately.
Fig. 4. Age-specific prevalence of exposure to chikungunya and dengue viruses and 




















CHIKV E1 DENV-2 DVLP DEN-3 DVLP MSP-1 antigens
2 to < 4 4 to < 6 6 to < 8 8 to < 10 10 to 14
CHIKV E1: chikungunya virus envelope 1; DVLP: dengue virus-like particle; MSP-1: merozoite surface protein 1.
Notes: Multiplex bead assays were used to investigate blood spots, from a cross-sectional sample of 127 
children, for immunoglobulin G responses to six antigens representing the three pathogens.
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ملخص
قياس معدل تعرض األطفال يف دولة هايتي إىل ُحى ِشيُكوْنُغوْنيا وُحى الضنك واملالريا
الغرض التمييز بني معدالت التعرض لفريوس ِشيُكوْنُغوْنيا الذي 
الضنك  لفريوس  التعرض  ومعدالت  مؤخًرا  عنه  الكشف  تم 
املتوّطن والعوامل األخرى املسببة لألمراض يف دولة هايتي.
أية  الكتشاف  للحبيبات  املتعددة  املقايسة  استخدمنا  الطريقة 
إىل مستضد   )G )IgG املناعي  الغلوبولني  استجابات من جانب 
لفريوس  مشاهبني  وجسيمني  ِشيُكوْنُغوْنيا،  لفريوس  مؤتلف 
الضنك، وثالثة مستضدات مؤتلفة لُطفيل املتصورة املنجلية. لقد 
خضعت  التي   )217 عددها  )البالغ  الدم  عينات  معظم  مجع  تم 
لالستقصاء من كل 61 طفاًل عىل مدى فرتة طويلة متتد بني عامي 
2011 و2014، ولكن يف عام 2014، تم مجع 127 عينة أخرى 
لقطاعات متعددة من األطفال.
 2011 عامي  بني  فيام  امُلجّمعة  العينات  من  أي  ُتظهر  مل  النتائج 
و2013 والبالغ عددها 153 نتائج إجيابية عن وجود استجابات 
من جانب IgG إىل املستضد املؤتلف لفريوس ِشيُكوْنُغوْنيا باستثناء 
عام  تم مجعها يف  التي  العينات  من   )61/48 (  % 78.7 يعادل  ما 
2014 وذلك من أصل العينات املستخرجة من جمموعة األطفال 
قطاعات،  عدة  من  املستخرجة  العينة  يف  طويلة.  فرتة  مدى  عىل 
96 طفاًل )فيام يعادل 75.6%(  تم اكتشاف تلك االستجابات يف 
وكان معدل انتشارها متشاهًبا يف مجيع الفئات العمرية. ويف نفس 
املالريا سوى  استجابات ملستضد  أية  اكتشاف  يتم  مل  العينة،  تلك 
انتشار  معدل  إمجايل  بلغ  بينام   )% 6.3 يعادل  )فيام  أطفال  ثامنية  يف 
الضنك  فريوس  مستضدات  إىل   IgG جانب  من  االستجابات 
60.6 % ) 127/77( واستمر يف االزدياد بثبات مع ازدياد العمر. 
وأوضح التحليل املكاين أن معدل انتشار االستجابات من جانب 
lgG إىل فريوس ِشيُكوْنُغوْنيا وأحد اجلسيمني املشاهبني لفريوس 
الضنك قد ازداد بتغيري موقع أخذ العينات من مدينة يوغان انتقااًل 
باجتاه املحيط.
ِشيُكوْنُغوْنيا  فريوس  انتشار  إىل  املصلية  األدلة  تشري  االستنتاج 
برسعة وبشّدة يف دولة هايتي. كام ُتظهر املقايسة املتعددة للحبيبات 
معدل  عىل  لإلرشاف  مناسًبا  مصلًيا  نظاًما  تصبح  أن  بإمكاهنا  أن 
االنتشار املصيل لعدة عوامل مسببة لألمراض يف نفس الوقت.
level of IgG responses to chikungunya 
virus and dengue virus antigens, run-
ning from an urban area towards the 
beach. One reason for this gradient may 
be the preference of Ae. aegypti and Ae. 
albopictus for habitats with relatively 
lower salinity and/or wind activity.38 
The relatively high density of the hu-
man population in the more urban 
areas we investigated may also favour 
transmission.
Our results relating to dengue virus 
were consistent with those of previous 
studies on dengue in Haiti. Prior to 1969, 
dengue virus had not been reported in 
Haiti. In a study conducted in Port-au-
Prince between 1969 and 1971, however, 
antibody responses to this pathogen 
were detected in 43%, 60% and 76% of 
the subjects aged 1–5, 6–10 and 41–50 
years, respectively.9 In 1996, in a later 
study in Port-au-Prince, 85% of the 
children aged 6–13 years who were 
screened with a neutralizing antibody 
test were found positive for at least one 
dengue virus serotype.39
Our results relating to chikungunya 
virus, although based on a relatively 
small sample, are consistent with those 
of an unpublished but much larger study 
conducted in early 2015. The subjects of 
this larger study, which was focused on 
malaria, were checked for IgG responses 
to the chikungunya virus we used in 
the bead assay. The seroprevalence of 
such responses was found to be 82% in 
urban areas throughout Haiti – similar 
to the 79% found in our urban study 
site – and only 45% in rural areas (Eric 
Rogier, CDC, Atlanta, USA, personal 
communication, February 2016). In 
Haiti, rural areas are generally at higher 
altitudes than urban areas and the cool 
temperatures at high altitudes tend to 
limit vector densities.
Multiplex bead assays have been 
found to be at least as sensitive as 
ELISA40–42 and are relatively efficient 
since they require only 125 nL of speci-
men per well, in a 96-well format, while 
accommodating up to 100 antigens or 
data points per well. They can deliver 
efficiencies of cost, sample and labour 
while providing the opportunity to 
monitor the prevalence of exposure 
to multiple pathogens simultaneously. 
By analysing fluctuations in IgG re-
sponses to several antigens over time, 
with multiple blood samples from the 
same individual, such assays could also 
define exposure histories. Given the 
confirmed autochthonous transmis-
sion of Zika virus in Haiti and across 
the Americas,20,43 exposure histories 
are urgently needed. At a time when 
funding for the surveillance of a single 
disease is becoming increasingly diffi-
cult to defend, the versatility offered by 
multiplex bead assays could permit the 
longitudinal and cost–effective moni-
toring of multiple pathogens within a 
single study. ■
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方法 我 们 采 用 多 重 微 球 试 验 以 检 测 免 疫 球 蛋
白 G (IgG) 对重组基孔肯雅病毒抗原、两种类似登革
病毒的微粒和三种重组恶性疟疾抗原的反应。 研究
中的大部分血样（217 例）是采用纵向方式在 2011 年
到 2014 年自 61 位儿童采集而来，但还有 127 例是采
用横断面儿童采样的方式于 2014 年采集而来。
结果 在纵向群组样本中，2011 年到 2013 年间采集
的 153 例样本中没有一例在 lgG 对基孔肯雅病毒
抗原有反应中显示阳性，但在 2014 年采集的样本
中 78.7% (48/61) 显示阳性。 在横断面样本中，我们
发现其中 96 位儿童 (75.6%) 存在此类反应，并且在所
有年龄段都有相似概率。 在相同样本中，仅在八位儿
童 (6.3%) 中检测到对疟疾抗原有反应。但整体而言，









Mesure de l’exposition des enfants haïtiens au chikungunya, à la dengue et au paludisme
Objectif Différentier l’exposition au virus chikungunya, récemment 
introduit, de l’exposition au virus de la dengue et à d’autres pathogènes 
endémiques en Haïti.
Méthodes Nous avons procédé à une analyse multiplex à l’aide de 
billes pour détecter les réponses de l’immunoglobuline G (IgG) à un 
antigène recombinant du virus chikungunya, à deux particules pseudo-
virales de la dengue et à trois antigènes recombinants de Plasmodium 
falciparum. La plupart des échantillons de sang (217) analysés ont été 
prélevés de façon longitudinale sur chacun des 61 enfants, entre 2011 
et 2014, et 127 autres ont été prélevés sur un échantillon transversal 
d’enfants en 2014.
Résultats Dans la cohorte longitudinale, aucun des 153 échantillons 
prélevés entre 2011 et 2013 n’affichait de réponse positive de l’IgG à 
l’antigène du virus chikungunya, mais 78,7% (48/61) de ceux prélevés 
en 2014 étaient en revanche positifs. Dans l’échantillon transversal, 
des réponses positives ont été relevées chez 96 enfants (75,6%), avec 
une prévalence similaire dans tous les groupes d’âge. Sur ce même 
échantillon, des réponses à l’antigène du paludisme n’ont été détectées 
que chez huit enfants (6,3%) mais la prévalence globale des réponses 
de l’IgG aux antigènes du virus de la dengue était de 60,6% (77/127) et 
augmentait progressivement avec l’âge. L’analyse géographique a révélé 
que la prévalence des réponses de l’IgG au virus du chikungunya et à 
l’une des particules pseudo-virales de la dengue diminuait à mesure que 
le site d’échantillonnage s’éloignait de la ville de Léogâne en direction 
de l’océan.
Conclusion Les preuves sérologiques indiquent que la propagation 
du virus du chikungunya en Haïti a été rapide et intense. L’analyse 
multiplex à l’aide de billes s’est avérée être une plate-forme sérologique 
appropriée pour contrôler simultanément la séroprévalence de plusieurs 
pathogènes.
Резюме
Измерение подверженности гаитянских детей воздействию чикунгуньи, денге и малярии
Цель Провести различия между подверженностью воздействию 
недавно интродуцированного вируса чикунгуньи и воздействию 
эндемического вируса лихорадки денге и других болезнетворных 
микроорганизмов в Гаити.
Методы С помощью мультиплексного анализа с использованием 
гранул авторы статьи выявили реакцию иммуноглобулина 
G (IgG) на антиген рекомбинантного вируса чикунгуньи, две 
вирусоподобные частицы денге и три антигена рекомбинантного 
паразита Plasmodium falciparum. Забор большинства (217) 
исследованных образцов крови совершался в течение 
нескольких лет у 61 ребенка между 2011 и 2014 годами, а 
127 образцов были взяты у детей в рамках профильной пробы 
в 2014 году.
Результаты Ни для одного из 153 образцов, отобранных 
между 2011 и 2013 годами у детей из когорты долгосрочного 
исследования для анализа на реакцию IgG на антиген вируса 
чикунгуньи, не был получен положительный результат; однако 
78,7% (48/61) образцов, полученных у детей из этой же группы в 
2014 году, дали положительный результат. В профильной выборке 
реакция была обнаружена у 96 (75,6%) детей и наблюдалась 
со схожей частотностью во всех возрастных группах. В той же 
выборке реакция на малярийный антиген была обнаружена 
только у восьми детей (6,3%), однако общая распространенность 
реакции IgG на антигены вируса денге составила 60,6% (77/127) и 
с возрастом стабильно увеличивалась. Анализ на распределение 
по местности показал, что распространенность реакции IgG на 
вирус чикунгуньи и вирусоподобные частицы денге уменьшалась 
по мере перемещения места отбора проб от города Леоган в 
сторону океана.
Вывод Выявленные серологические реакции свидетельствуют 
о произошедшем скоротечном и усиленном распространении 
вируса чикунгуньи в Гаити. Мультиплексный анализ с 
использованием гранул служит подходящей базой для 
серодиагностики для одновременного отслеживания 
распространенности положительных серологических реакций 
на несколько болезнетворных микроорганизмов.
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Resumen
Medición de la exposición de los niños haitianos a la fiebre chikungunya, el dengue y la malaria
Objetivo Diferenciar la exposición al nuevo virus chikungunya de la 
exposición al virus endémico del dengue y a otros patógenos en Haití.
Métodos Se utilizó un ensayo multiplex de microesferas para detectar 
las respuestas de la inmunoglobulina G (IgG) ante un antígeno 
recombinante del virus chikungunya, dos partículas similares al virus del 
dengue y tres antígenos recombinantes de Plasmodium falciparum. La 
mayoría (217) de las muestras de sangre investigadas se recogieron de 
forma longitudinal, de cada uno de los 61 niños, entre 2011 y 2014, pero 
en 2014 también se recogieron otras 127 de una muestra transversal 
de niños.
Resultados De las muestras de la cohorte longitudinal, ninguna de las 
153 muestras recogidas entre 2011 y 2013 dio un resultado positivo 
de respuestas de la IgG al antígeno del virus chikungunya, pero sí que 
lo dieron el 78,7% (48/61) de las muestras recogidas en 2014. En la 
muestra transversal, se detectaron dichas respuestas en 96 (75,6%) de 
los niños y se mostró una prevalencia similar en todos los grupos de 
edades. En la misma muestra, únicamente se detectaron respuestas 
al antígeno de la malaria en ocho niños (6,3%), aunque la prevalencia 
de las respuestas de la IgG a los antígenos del virus del dengue fue del 
60,6% (77/127) en general y aumentaba de forma estable con la edad. 
Los análisis territoriales indicaron que la prevalencia de las respuestas 
de la IgG al virus chikungunya y a una de las partículas similares al virus 
del dengue se redujo conforme el lugar de la muestra se alejaba de la 
ciudad de Léogâne y se acercaba al océano.
Conclusión La prueba serológica indica que se ha producido una 
diseminación rápida e intensa del virus chikungunya en Haití. Parece 
que el ensayo multiplex de microesferas es una plataforma serológica 
adecuada para supervisar la seroprevalencia de varios patógenos al 
mismo tiempo.
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Fig. 5. Spatial analysis of fluorescence intensities recorded in multiplex bead 
assays based on antigens representing chikungunya and dengue viruses and 
Plasmodium falciparum, Haiti, 2014
Study site, to north-west of Léogâne
19-kDa MSP-1 fragment, linked to GST
CHIKV E1
DENV-2 DVLP
<-2.0 -2.0 to -1.0 -1.0 to 1.0 1.0 to 2.0 >2.0G,Z score
CHIKV E1: chikungunya virus envelope 1; DVLP: dengue virus-like particle; GST: glutathione-S-transferase; 
MSP-1: merozoite surface protein 1.
Notes: The assays were used, with three test antigens, to investigate blood spots from a cross-sectional 
sample of 127 children. In the spatial analysis of the data, Z scores for the Getis–Ord Gi statistic were 
aggregated and displaced from their actual locations. Blue and red circles indicate, respectively, so called 
low spots and high spots – i.e. clusters where children had immunoglobulin G responses to the test 
antigen that were significantly lower and higher, respectively, than the mean value.
